Syensqo (SYENS) Q1 2025 earnings summary

Executive summary

• Q1 2025 net sales were €1.62 billion, flat year-over-year, with stable pricing and a 1% decline in volumes; sequential sales rose 1% due to higher pricing.

• Composite Materials and Technology Solutions delivered double-digit growth, while Specialty Polymers declined; overall EBITDA was €311 million, down 15% year-over-year but up 5% sequentially, with a 19.2% margin.

• Free cash flow was €37 million, impacted by capex phasing; operating cash flow was €176 million.

• Share buyback program repurchased approximately 758,000 shares for €56 million in Q1 2025, with about 40% of the €300 million program completed.

• Significant progress in Solvay separation, with most IT and ERP systems exited and restructuring underway, including a proposed reduction of ~200 positions.

Financial highlights

• Net sales: €1,619 million, down 0.3% year-over-year, up 1.3% sequentially; gross profit: €514 million, margin 31.7%, down 420 bps YoY, up 160 bps QoQ.

• Underlying EBITDA: €311 million, margin 19.2%, down 310 bps YoY, up 60 bps QoQ.

• Free cash flow: €37 million, down from €157 million YoY; operating cash flow: €176 million.

• Net financial debt: €1,932 million; leverage ratio: 1.4x; gearing ratio: 22%.

• ROCE (LTM): 7.1%, down 250 bps YoY.

Outlook and guidance

• FY 2025 outlook unchanged: underlying EBITDA of at least €1.4 billion, capex ~€600 million, free cash flow ~€400 million.

• Q2 2025 EBITDA expected to improve sequentially; H2 2025 anticipated to outperform H1, driven by Electronics and Civil Aviation.

• Cost savings and restructuring to accelerate, targeting €200 million run-rate savings by end of 2026 and ~200 position reductions.

• Excludes potential impacts from tariffs and FX volatility in guidance.

• Capex expected to decline significantly in 2026 as major projects and separation costs wind down.